Peter A. Altman
Net Worth
Last updated:
What is Peter A. Altman net worth?
The estimated net worth of Dr. Peter A. Altman is at least $2,869,834 as of 23 Dec 2024. He owns shares worth $202,323 as insider, has earned $7,581 from insider trading and has received compensation worth at least $2,659,930 in BioCardia, Inc..
What is the salary of Peter A. Altman?
Dr. Peter A. Altman salary is $379,990 per year as Chief Executive Officer, Pres & Director in BioCardia, Inc..
How old is Peter A. Altman?
Dr. Peter A. Altman is 58 years old, born in 1967.
What stocks does Peter A. Altman currently own?
As insider, Dr. Peter A. Altman owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
BioCardia, Inc. (BCDA) | Chief Executive Officer, Pres & Director | 106,581 | $1.9 | $202,323 |
What does BioCardia, Inc. do?
BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.
Peter A. Altman insider trading
BioCardia, Inc.
Dr. Peter A. Altman has made only one insider trade between 2018-2024, according to the Form 4 filled with the SEC. He purchased 1,000 units of BCDA stock worth $2,060 on 23 Dec 2024.
As of 23 Dec 2024 he still owns at least 106,581 units of BCDA stock.
BioCardia key executives
BioCardia, Inc. executives and other stock owners filed with the SEC:
- Dr. Peter A. Altman (58) Chief Executive Officer, Pres & Director
- Mr. David McClung (62) Chief Financial Officer